Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.
Explore NowDelveInsight’s ‘Night Vision Disturbances (NVD)––Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Night vision disturbance (NVD), historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Study Period: 2018–2030
Night vision disturbance (NVD) describes a decrease in the quality of vision secondary to glare disability, with decreased contrast sensitivity and consequential image degradation.
Most complaints of image degradations occur under scotopic (vision in dim light; from 10−6 to 10−3 cd/m2) or mesopic (a combination of photopic (cons) vision and scotopic (rods) vision in low but not quite dark lighting situations; from 10−3 to 3 cd/m2) conditions when the pupil is physiologically dilated, most often in conditions such as night driving thus, NVD is an appropriate term used for such combinations of events.
Night Vision Disturbances (NVD) symptoms are glare, hallos, starburst, ghosting, image degradation, and contrast sensitivity.
NVD can be classified into four categories. Most people have limited visual problems, which can be corrected by simple and effective therapies. Some people have major issues who are tried to bring their vision to near normal. The categories of night vision impairments are Blurred vision in dim light, Blinding glare or halos around light, insufficient perception of dim light, Combination of two or more of the above conditions
There are no approved therapies for this condition; the best-suited treatment for this indication requires identifying the source. Other procedures include refractive correction, surgical corrections, and methods for constricting the pupil.
As there are more symptomatic treatments, the current need is to correct or prevent high order aberrations, develop an accurate clinical test, and standardize the clinical terms in a more elaborated and better way for the proper understanding of the disease.
The Night Vision Disturbances (NVD) epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Findings
The disease epidemiology covered in the report provides historical as well as forecasted Night Vision Disturbances (NVD) epidemiology segmented as the Total Incident Cases of Night Vision Disturbances (NVD), Incident cases of Night Vision Disturbances (NVD) by Type of Surgeries, Incidence of Night Vision Disturbances (NVD) Manifestations. The report includes the Incident scenario of Night Vision Disturbances (NVD) symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.
The epidemiology segment also provides the Night Vision Disturbances (NVD) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The total Incident population of Night Vision Disturbances (NVD) associated in 7MM countries was estimated to be 3,128,058 cases in 2020 and expected to increase at a CAGR of 0.60 % for the study period, i.e., 2018–2030.
We interview KOLs, and SME’s opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
The Night Vision Disturbances (NVD) Epidemiology report will allow the user to -
1. Key Insights
2. Report Introduction
3. Night Vision Disturbances Market Overview at a Glance
3.1. Market Share (%) Distribution of Night Vision Disturbances in 2018
3.2. Market Share (%) Distribution of Night Vision Disturbances in 2030
4. Executive Summary of Night Vision Disturbances
5. NVD Market: Future Perspective
6. Disease Background and Overview
6.1. Introduction
6.2. Types of NVD
6.3. Causes and risk factors
6.4. Symptoms
6.5. Diagnosis
7. Epidemiology and Patient Population
7.1. Key Findings
7.2. 7MM Total Incident Patient Population of Night Vision Disturbances
7.3. Assumption and Rationale
7.4. The United States
7.4.1. Total Incident Cases of NVD in the United States
7.4.2. Incident cases of NVD by Type of Surgeries in the United States
7.4.3. Incidence of NVD Manifestations in the United States
7.5. EU5
7.5.1. Germany
7.5.1.1. Total Incident Cases of NVD in Germany
7.5.1.2. Incident cases of NVD by Type of Surgeries in Germany
7.5.1.3. Incidence of NVD Manifestations in Germany
7.5.2. France
7.5.2.1. Total Incident Cases of NVD in France
7.5.2.2. Incident cases of NVD by Type of Surgeries in France
7.5.2.3. Incidence of NVD Manifestations in France
7.5.3. Italy
7.5.3.1. Total Incident Cases of NVD in Italy
7.5.3.2. Incident cases of NVD by Type of Surgeries in Italy
7.5.3.3. Incidence of NVD Manifestations in Italy
7.5.4. Spain
7.5.4.1. Total Incident Cases of NVD in Spain
7.5.4.2. Incident cases of NVD by Type of Surgeries in Spain
7.5.4.3. Incidence of NVD Manifestations in Spain
7.5.5. United Kingdom
7.5.5.1. Total Incident Cases of NVD in the United Kingdom
7.5.5.2. Incident cases of NVD by Type of Surgeries in the United Kingdom
7.5.5.3. Incidence of NVD Manifestations in the United Kingdom
7.6. Japan
7.6.1. Total Incident Cases of NVD in Japan
7.6.2. Incident cases of NVD by Type of Surgeries in Japan
7.6.3. Incidence of NVD Manifestations in Japan
8. Treatment
9. Organizations contributing towards Night Vision Disturbances
10. Case Reports
11. Patient Journey
12. Appendix
12.1. Bibliography
12.2. Report Methodology
13. DelveInsight Capabilities
14. Disclaimer
15. About DelveInsight
List of Table
Table 1: Summary of NVD, Market, Epidemiology, and Key Events (2018–2030)
Table 2: List of different diagnostic tests for NVD:
Table 3: Incident Patient Population of Night Vision Disturbances in 7MM in 000’s (2018–2030)
Table 4: Total Incident Cases of NVD in the United States in 000’s (2018–2030)
Table 5: Incident cases of NVD by Type of Surgeries in the United States in 000’s (2018–2030)
Table 6: Incidence of NVD Manifestations in the United States in 000’s (2018–2030)
Table 7: Total Incident Cases of NVD in Germany in 000’s (2018–2030)
Table 8: Incident cases of NVD by Type of Surgeries in Germany in 000’s (2018–2030)
Table 9: Incidence of NVD Manifestations in Germany in 000’s (2018–2030)
Table 10: Total Incident Cases of NVD in France in 000’s (2018–2030)
Table 11: Incident cases of NVD by Type of Surgeries in France in 000’s (2018–2030)
Table 12: Incidence of NVD Manifestations in France in 000’s (2018–2030)
Table 13: Total Incident Cases of NVD in Italy in 000’s (2018–2030)
Table 14: Incident cases of NVD by Type of Surgeries in Italy in 000’s (2018–2030)
Table 15: Incidence of NVD Manifestations in Italy in 000’s (2018–2030)
Table 16: Total Incident Cases of NVD in Spain in 000’s (2018–2030)
Table 17: Incident cases of NVD by Type of Surgeries in Spain in 000’s (2018–2030)
Table 18: Incidence of NVD Manifestations in Spain in 000’s (2018–2030)
Table 19: Total Incident Cases of NVD in United Kingdom in 000’s (2018–2030)
Table 20: Incident cases of NVD by Type of Surgeries in the United Kingdom in 000’s(2018–2030)
Table 21: Incidence of NVD Manifestations in the United Kingdom in 000’s (2018–2030)
Table 22: Total Incident Cases of NVD in Japan in 000’s (2018–2030)
Table 23: Incident cases of NVD by Type of Surgeries in Japan in 000’s (2018–2030)
Table 24: Incidence of NVD Manifestations in Japan in 000’s (2018–2030)
List of Figures
Figure 1: Risk factors associated with NVD
Figure 1: Symptoms of NVD
Figure 4: Incident Patient Population of Night Vision Disturbances in 7MM (2018–2030)
Figure 5: Total Incident Cases of NVD in the United States (2018–2030)
Figure 6: Incident cases of NVD by Type of Surgeries in the United States (2018–2030)
Figure 7: Incidence of NVD Manifestations in the United States (2018–2030)
Figure 8: Total Incident Cases of NVD in Germany (2018–2030)
Figure 9: Incident cases of NVD by Type of Surgeries in Germany (2018–2030)
Figure 10: Incidence of NVD Manifestations in Germany (2018–2030)
Figure 11: Total Incident Cases of NVD in France (2018–2030)
Figure 12: Incident cases of NVD by Type of Surgeries in France (2018–2030)
Figure 13: Incidence of NVD Manifestations in France (2018–2030)
Figure 14: Total Incident Cases of NVD in Italy (2018–2030)
Figure 15: Incident cases of NVD by Type of Surgeries in Italy (2018–2030)
Figure 16: Incidence of NVD Manifestations in Italy (2018–2030)
Figure 17: Total Incident Cases of NVD in Spain (2018–2030)
Figure 18: Incident cases of NVD by Type of Surgeries in Spain (2018–2030)
Figure 19: Incidence of NVD Manifestations in Spain (2018–2030)
Figure 20: Total Incident Cases of NVD in the United Kingdom (2018–2030)
Figure 21: Incident cases of NVD by Type of Surgeries in the United Kingdom (2018–2030)
Figure 22: Incidence of NVD Manifestations in the United Kingdom (2018–2030)
Figure 23: Total Incident Cases of NVD in Japan (2018–2030)
Figure 24: Incident cases of NVD by Type of Surgeries in Japan (2018–2030)
Figure 25: Incidence of NVD Manifestations in Japan (2018–2030)
